Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT-Reference-Cited by-同舟云学术

Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT

Published:2017-09 Issue:9 Volume:23 Page:1422-1428
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Dietz Andrew C.^ORCID,Savage Sharon A.,Vlachos Adrianna,Mehta Parinda A.,Bresters Dorine,Tolar Jakub,Bonfim Carmem,Dalle Jean Hugues,de la Fuente Josu,Skinner Roderick,Boulad Farid,Duncan Christine N.,Baker K. Scott,Pulsipher Michael A.,Lipton Jeffrey M.,Wagner John E.,Alter Blanche P.^ORCID

Funder

National Institutes of Health

Pediatric Blood and Marrow Transplant Consortium, and St. Baldrick's Foundation

Intramural Research Program of the National Cancer Institute

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference70 articles.

1. Prevalence of hematopoietic cell transplant survivors in the United States;Majhail;Biol Blood Marrow Transplant,2013

2. Improved overall survival for pediatric patients undergoing allogeneic hematopoietic stem cell transplantation–A comparison of the last two decades;Svenberg;Pediatr Transplant,2016

3. Reduced mortality after allogeneic hematopoietic-cell transplantation;Gooley;N Engl J Med,2010